Saturday, October 31, 2026

Beyond Meat Stock Is 9% Up So Far On Friday

ViaNews Editorial Team

February 24, 2023

Beyond Meat Stock Is 9% Up So Far On Friday

(VIANEWS) - Shares of Beyond Meat (NASDAQ: BYND) jumped 9.32% to $18.74 at 13:34 EST on Friday, after two successive sessions in a row of gains. NASDAQ is sliding 2.15% to $11,341.62, after two sequential sessions in a row of gains. This seems, up until now, an all-around down trend trading session today.

Beyond Meat's last close was $17.14, 67.94% below its 52-week high of $53.47.

About Beyond Meat

Beyond Meat, Inc. manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club store, convenience store and natural retailer channels, and direct-to-consumer, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools. The company was formerly known as Savage River, Inc. and changed its name to Beyond Meat, Inc. in September 2018. Beyond Meat, Inc. was founded in 2009 and is headquartered in El Segundo, California.

Earnings Per Share

As for profitability, Beyond Meat has a trailing twelve months EPS of $-0.85.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -1167.03%.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is 7.1% and 35.4%, respectively.

Volatility

Beyond Meat's last week, last month's, and last quarter's current intraday variation average was a negative 1.22%, a positive 0.57%, and a positive 4.47%.

Beyond Meat's highest amplitude of average volatility was 4.22% (last week), 5.27% (last month), and 4.47% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 22.5%, now sitting on 439.67M for the twelve trailing months.

More news about Beyond Meat (BYND).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com